Growth Metrics

Ironwood Pharmaceuticals (IRWD) Deferred Taxes (2021 - 2026)

Ironwood Pharmaceuticals' Deferred Taxes history spans 5 years, with the latest figure at -$1.7 million for Q4 2025.

  • On a quarterly basis, Deferred Taxes fell 104.25% to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.8 million, a 40.08% decrease, with the full-year FY2025 number at $40.8 million, down 40.08% from a year prior.
  • Deferred Taxes hit -$1.7 million in Q4 2025 for Ironwood Pharmaceuticals, down from $27.8 million in the prior quarter.
  • Over the last five years, Deferred Taxes for IRWD hit a ceiling of $41.1 million in Q4 2024 and a floor of -$1.7 million in Q4 2025.
  • Historically, Deferred Taxes has averaged $14.0 million across 5 years, with a median of $14.2 million in 2023.
  • Biggest five-year swings in Deferred Taxes: surged 941.33% in 2022 and later crashed 104.25% in 2025.
  • Tracing IRWD's Deferred Taxes over 5 years: stood at $1.9 million in 2021, then surged by 941.33% to $20.1 million in 2022, then soared by 55.6% to $31.3 million in 2023, then soared by 31.23% to $41.1 million in 2024, then tumbled by 104.25% to -$1.7 million in 2025.
  • Business Quant data shows Deferred Taxes for IRWD at -$1.7 million in Q4 2025, $27.8 million in Q3 2025, and $14.1 million in Q2 2025.